Literature DB >> 4601181

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.

G W Jordan, R P Fried, T C Merigan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4601181     DOI: 10.1093/infdis/130.1.56

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  Inhibition of Herpesvirus hominis replication by human interferon.

Authors:  L Rasmussen; L B Farley
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas.

Authors:  D Neumann-Haefelin; R Sundmacher; B Sauter; H E Karges; K F Manthey
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

Review 3.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

Review 4.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

Review 5.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

Review 6.  Antiviral agents: an update--Part 2.

Authors:  S Bogger-Goren; P L Ogra
Journal:  Indian J Pediatr       Date:  1980 Nov-Dec       Impact factor: 1.967

Review 7.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

8.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 9.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 10.  The interferons.

Authors:  J L Toy
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.